Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
BNGO
$1.00
-3.85%
BNGO
· Bionano Genomics, Inc.
$1.00
-0.04 (-3.85%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, we determined that there is substantial doubt about our ability to continue as a going concern within 12 months after the date that the financial statements included in this Quarterly Report are issued.”View the 10-Q filed Nov 10, 2026
Market Cap
$13.99M
Shares
13.99M
Volume · Nov 13
557.57K
Avg daily vol (3M)
965.62K
All webcasts
Earnings call · FY2021 Q1
Bionano Genomics, Inc. (BNGO) Q1 2021 Earnings Call
Revenue
$3.17M
+178.9% YoY
Diluted EPS
-$24.00
Gross margin · derived Q4
32.9%
+8.3 pp YoY
Net income
-$9.95M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed May 13, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed May 13, 2021 · complete as-filed document